The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_004992.3(MECP2):c.1180G>A (p.Glu394Lys)

CA170197

143421 (ClinVar)

Gene: MECP2
Condition: Rett syndrome
Inheritance Mode: X-linked inheritance
UUID: cb6d3431-d972-4851-bc8e-700dee1752ff
Approved on: 2021-03-26
Published on: 2021-05-17

HGVS expressions

NM_004992.3:c.1180G>A
NM_004992.3(MECP2):c.1180G>A (p.Glu394Lys)
ENST00000303391.11:c.1180G>A
ENST00000453960.7:c.1216G>A
ENST00000303391.10:c.1180G>A
ENST00000407218.5:c.*552G>A
ENST00000453960.6:c.1216G>A
ENST00000619732.4:c.1180G>A
ENST00000628176.2:c.*552G>A
NM_001110792.1:c.1216G>A
NM_001316337.1:c.901G>A
NM_001110792.2:c.1216G>A
NM_001316337.2:c.901G>A
NM_001369391.2:c.901G>A
NM_001369392.2:c.901G>A
NM_001369393.2:c.901G>A
NM_001369394.1:c.901G>A
NM_001369394.2:c.901G>A
NM_001386137.1:c.511G>A
NM_001386138.1:c.511G>A
NM_001386139.1:c.511G>A
NM_004992.4:c.1180G>A
NC_000023.11:g.154030648C>T
CM000685.2:g.154030648C>T
NC_000023.10:g.153296099C>T
CM000685.1:g.153296099C>T
NC_000023.9:g.152949293C>T
NG_007107.2:g.111480G>A
NG_007107.3:g.111456G>A
More

Benign

Met criteria codes 4
BA1 BS2 BP5 BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The allele frequency of the p.Glu394Lys variant in MECP2 is 0.035% in East Asian sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Glu394Lys variant is observed in at least 2 unaffected individuals (internal database) (BS2). Computational analysis prediction tools suggest that the p.Glu394Lys variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Glu394Lys variant is found in a patient with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Glu394Lys variant in MECP2 is classified as benign based on the ACMG/AMP criteria (BA1, BS2, BP4, BP5).
Met criteria codes
BA1
The allele frequency of the p.Glu394Lys variant in MECP2 is 0.035% in East Asian sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions.
BS2
The p.Glu394Lys variant is observed in at least 2 unaffected individuals (internal database)
BP5
The p.Glu394Lys variant is found in a patient with an alternate molecular basis of disease (internal database)
BP4
Computational analysis prediction tools suggest that the p.Glu394Lys variant does not have a deleterious impact; however this information does not predict clinical significance on its own
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.